Table 1.
Results of EMab-51 and EMab-134 Immunostaining in 48 Patients with Oral Cancers
| No. | Sex | Age | Organ | Pathology diagnosis | Differentiation | Type | EMab-51 | EMab-134 |
|---|---|---|---|---|---|---|---|---|
| 1 | M | 61 | Tongue | SCC | Well | Malignant | 0 | 0 |
| 2 | F | 57 | Tongue | SCC | Well | Malignant | 0 | 1+ |
| 3 | F | 67 | Tongue | SCC | Well | Malignant | 0 | 2+ |
| 4 | M | 59 | Tongue | SCC | Well | Malignant | 0 | 1+ |
| 5 | F | 47 | Tongue | SCC | Well | Malignant | 0 | 1+ |
| 6 | F | 62 | Tongue | SCC | — | Malignant | 0 | 3+ |
| 7 | F | 47 | Tongue | SCC | Well | Malignant | 0 | 2+ |
| 8 | M | 51 | Tongue | SCC | Well | Malignant | 0 | 0 |
| 9 | M | 62 | Tongue | SCC | Well | Malignant | 0 | 2+ |
| 10 | F | 53 | Tongue | SCC | Well | Malignant | 0 | 3+ |
| 11 | M | 50 | Tongue | SCC | Well | Malignant | 0 | 3+ |
| 12 | M | 76 | Tongue | SCC | Well | Malignant | 0 | 3+ |
| 13 | M | 55 | Tongue | SCC | Well | Malignant | 0 | 1+ |
| 14 | F | 57 | Tongue | SCC | Moderately | Malignant | 0 | 1+ |
| 15 | M | 61 | Tongue | SCC | Well | Malignant | 3+ | 3+ |
| 16 | F | 50 | Tongue | SCC | Well | Malignant | 0 | 2+ |
| 17 | M | 54 | Tongue | SCC | Well | Malignant | 0 | 2+ |
| 18 | M | 62 | Tongue | SCC | Well | Malignant | 0 | 1+ |
| 19 | F | 55 | Tongue | SCC | Well | Malignant | 2+ | 3+ |
| 20 | F | 63 | Tongue | SCC | Well | Malignant | 0 | 1+ |
| 21 | M | 56 | Tongue | SCC | Well | Malignant | 0 | 1+ |
| 22 | F | 45 | Tongue | SCC | Well | Malignant | 0 | 3+ |
| 23 | M | 50 | Tongue | SCC | Well | Malignant | 2+ | 3+ |
| 24 | F | 46 | Tongue | SCC | Poorly | Malignant | 0 | 3+ |
| 25 | F | 48 | Tongue | SCC | Moderately | Malignant | 0 | 2+ |
| 26 | F | 67 | Tongue | SCC | — | Malignant | 0 | 2+ |
| 27 | M | 64 | Tongue | SCC | Poorly | Malignant | 1+ | 3+ |
| 28 | F | 50 | Tongue | SCC | Moderately | Malignant | 0 | 1+ |
| 29 | M | 63 | Tongue | SCC | Moderately | Malignant | 0 | 2+ |
| 30 | F | 46 | Tongue | SCC | Well | Malignant | 0 | 2+ |
| 31 | F | 35 | Tongue | SCC | Moderately | Malignant | 0 | 2+ |
| 32 | M | 55 | Tongue | SCC | Poorly | Malignant | 0 | 1+ |
| 33 | M | 49 | Tongue | SCC | Poorly | Malignant | 0 | 2+ |
| 34 | M | 61 | Tongue | SCC | Moderately | Malignant | 0 | 1+ |
| 35 | M | 53 | Tongue | SCC | Moderately | Malignant | 1+ | 3+ |
| 36 | F | 51 | Tongue | SCC | Poorly | Malignant | 0 | 2+ |
| 37 | M | 73 | Tongue | SCC | Poorly | Malignant | 0 | 2+ |
| 38 | M | 61 | Tongue | SCC | Poorly | Malignant | 1+ | 3+ |
| 39 | M | 62 | Tongue | ACC | — | Malignant | 0 | 0 |
| 40 | M | 50 | Tongue | MC | — | Malignant | 0 | 0 |
| 41 | M | 68 | Parotid | PA | — | Malignant | 0 | 1+ |
| 42 | M | 58 | Parotid | PA | — | Malignant | 0 | 0 |
| 43 | M | 41 | Parotid | PA | — | Malignant | 0 | 0 |
| 44 | F | 45 | Parotid | MPA | — | Malignant | 0 | 0 |
| 45 | M | 57 | Parotid | MPA | — | Malignant | 0 | 1+ |
| 46 | M | 52 | Parotid | MPA | — | Malignant | 0 | 1+ |
| 47 | M | 65 | Parotid | AL | — | Malignant | 0 | 1+ |
| 48 | F | 74 | Parotid | ACC | — | Malignant | 0 | 1+ |
ACC, adenoid cystic carcinoma; AL, adenolymphoma; F, female; M, male; MC, mucoepidermoid carcinoma; MPA, malignant pleomorphic adenoma; PA, pleomorphic adenoma; SCC, squamous cell carcinoma.